Effect of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin

NCT03063580 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Sotagliflozin (SAR439954)
DRUG: Rifampicin

Sponsor

Sanofi